What is BioTuring?
BioTuring is at the forefront of revolutionizing multi-omics and spatial biology by leveraging advanced deep learning technologies. The company offers a suite of sophisticated platforms designed to empower scientists and researchers in bioinformatics. These include SpatialX for in-depth spatial biology data analysis, BBrowserX for comprehensive single-cell RNA-sequencing data exploration, and SmartBulk for efficient bulk RNA-sequencing data processing. BioTuring's mission is to equip over 10,000 scientists and numerous institutions globally with cutting-edge tools and resources, thereby accelerating their research capabilities and discoveries in the complex fields of biological data analysis and visualization.
How much funding has BioTuring raised?
BioTuring has raised a total of $1M across 1 funding round:
Private Equity
$1M
Private Equity (2017): $1M, investors not publicly disclosed
What's next for BioTuring?
With a major enterprise-level funding context and a recent strategic investment, BioTuring is well-positioned for significant expansion and technological advancement. The substantial capital infusion is expected to fuel further development of its deep learning platforms, enhancing their analytical power and user accessibility. This strategic backing will likely enable BioTuring to broaden its market reach, solidify its position as a leader in bioinformatics solutions, and support a growing community of researchers in their pursuit of groundbreaking scientific insights. The company's focus on multi-omics and spatial biology indicates a strategic direction towards addressing some of the most complex challenges in biological research.
See full BioTuring company page
